Research Article
CCL3 Promotes Proliferation of Colorectal Cancer Related with TRAF6/NF-κB Molecular Pathway
Table 2
Correlation analysis of CCL3 expression and clinical data in human colorectal cancer tissue.
| | Group | n | CCL3 expression | χ2 | | | High | Moderate | Low | Loss |
| | Gender | | Male | 26 | 5 | 14 | 6 | 1 | 3.559 | 0.313 | | Female | 24 | 3 | 16 | 2 | 3 | | Age | | ≤60 years | 19 | 3 | 14 | 1 | 1 | 5.949 | 0.114 | | >60 years | 31 | 5 | 15 | 8 | 3 | | Tumor site | | Rectum | 22 | 2 | 16 | 4 | 0 | 5.785 | 0.123 | | Colon | 28 | 6 | 13 | 5 | 4 | | TNM stage | | I | 14 | 1 | 4 | 8 | 1 | 18.442 | 0.005 | | II | 17 | 4 | 9 | 3 | 1 | | III | 19 | 4 | 13 | 0 | 2 | | Differentiation (grade) | | Well | 7 | 0 | 4 | 2 | 1 | 9.95 | 0.127 | | Moderate | 30 | 6 | 18 | 4 | 2 | | Poor | 13 | 7 | 4 | 1 | 1 | | Lymph-vascular space invasion | | Present | 16 | 3 | 9 | 3 | 1 | 0.73 | 0.886 | | Absent | 34 | 5 | 20 | 6 | 3 | | Perineural invasion | | Present | 22 | 3 | 16 | 3 | 0 | 5.165 | 0.16 | | Absent | 28 | 5 | 13 | 6 | 4 |
|
|